Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hinova PharmaceuticalsSHSE:688302 -14.81%24 Days Inventory is 7,328.15 as of Mar. 2026, which is 154177% above its 10-year median of 4.75. GuruFocus rates SHSE:688302 with a GF Score™ of 24/100. The stock has 2 warning signs investors should review. Among 638 Biotechnology companies, Hinova Pharmaceuticals ranks worse than 95.45% on this metric.
The historical rank and industry rank for Hinova Pharmaceuticals's Days Inventory or its related term are showing as below:
SHSE:688302'
s Days Inventory Range Over the Past 10 Years
Min: 2.62 Med: 4.75 Max: 2264.76
Current: 2264.76
During the past 8 years, Hinova Pharmaceuticals's highest Days Inventory was 2264.76. The lowest was 2.62. And the median was 4.75.
SHSE:688302's Days Inventory is ranked worse than 95.45% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs SHSE:688302: 2264.76
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Hinova Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.01.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Hinova Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.15.
Hinova Pharmaceuticals (SHSE:688302) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Hinova Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Hinova Pharmaceuticals's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Hinova Pharmaceuticals Days Inventory Related Terms
Hinova Pharmaceuticals Days Inventory Historical Data
* Premium members only.
The historical data trend for Hinova Pharmaceuticals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688302 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Hinova Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hinova Pharmaceuticals Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Hinova Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Hinova Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hinova Pharmaceuticals (SHSE:688302) has a Days Inventory of 7,328.15 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Hinova Pharmaceuticals and its competitors. This is 154177% above median its historical median of 4.75. Over the past decade, Hinova Pharmaceuticals' Days Inventory has ranged from 2.62 to 2,264.76. According to the industry distribution chart, Hinova Pharmaceuticals ranks #609 out of 638 companies in the Biotechnology industry, placing it in the top 95.5%.
Is Hinova Pharmaceuticals' Days Inventory too high?
Hinova Pharmaceuticals' current Days Inventory of 7,328.15 is 154177% above median its 10-year median of 4.75. Over the past 10 years, this metric has ranged from a low of 2.62 to a high of 2,264.76. The Biotechnology industry median Days Inventory is 183.20. Hinova Pharmaceuticals' value of 7,328.15 is 3900.2% above this industry median. Based on the distribution chart, Hinova Pharmaceuticals ranks #609 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Hinova Pharmaceuticals has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Hinova Pharmaceuticals' Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Hinova Pharmaceuticals ranks #609 out of 638 companies for Days Inventory. This places Hinova Pharmaceuticals in the lower half of its industry. The industry median Days Inventory is 183.20. Hinova Pharmaceuticals' value of 7,328.15 is 3900.2% above this benchmark. Historically, Hinova Pharmaceuticals' own Days Inventory has ranged from 2.62 to 2,264.76 over the past decade. While the company's 10-year median is 4.75 vs. the industry median of 183.20, Hinova Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hinova Pharmaceuticals's current Days Inventory of 7,328.15 is 3900.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Hinova Pharmaceuticals and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hinova Pharmaceuticals's current Days Inventory is 7,328.15, which is 154177% above median its own 10-year median of 4.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hinova Pharmaceuticals stock overvalued right now?
Hinova Pharmaceuticals (SHSE:688302) has a current Days Inventory of 7,328.15. The current Days Inventory is 7,328.15, which is 154177% above median its 10-year median of 4.75 and 3900.2% above the Biotechnology industry median of 183.20. Hinova Pharmaceuticals' overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Hinova Pharmaceuticals (SHSE:688302), the current Days Inventory is 7,328.15 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hinova Pharmaceuticals Inc is an international drug company based on technology platforms such as deuterium and PROTAC, aiming to develop Best-in-class and First-in-class drugs with major clinical needs. The company focuses on the research and development of drugs in therapeutic areas such as oncology and metabolic diseases, focusing on providing safe, effective and affordable drugs for patients, and is committed to the development and production of drugs with global rights and interests.
24GF Score
Get the complete analysis for SHSE:688302
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688302 has been successfully added to your 
